Ducasse
Cecille Ducasse, Lyon FR
Patent application number | Description | Published |
---|---|---|
20080312143 | Modified Cdna for High Expression Levels of Factor VIII and Its Derivatives - The present invention relates to modified DNA sequences coding for biologically active recombinant human factor VIII and its derivatives, recombinant expression vectors containing such DNA sequences, host cells transformed with such recombinant expression vectors, and processes for the manufacture of the recombinant human factor VIII and its derivatives. The invention also covers a transfer vector for use in human gene therapy which comprises such modified DNA sequences. The present invention relates to modified DNA sequences coding for biologically active recombinant human factor VIII and its derivatives, recombinant expression vectors containing such DNA sequences, host cells transformed with such recombinant expression vectors, and processes for the manufacture of the recombinant human factor VIII and its derivatives. The invention also covers a transfer vector for use in human gene therapy which comprises such modified DNA sequences. | 12-18-2008 |
Sheila Beverly Ducasse, Gaithersburg, MD US
Patent application number | Description | Published |
---|---|---|
20150089709 | HAT WITH WRAP-AROUND SUN SHADE - According to one embodiment of the present invention, the article or piece of clothing includes a hat having a crown and a bill extending outwardly from the crown. A wrap-around shoulder-length sun shade or sun screen is releasably coupled, by separating zippers, to the crown and bill of the hat. If the separating zippers are closed, the wrap-around shade or wrap around screen is connected to the crown and bill. If the separating zippers are open, the wrap-around sun shade or sun screen can be detached from the crown and/or the bill. | 04-02-2015 |
Stephanie Ducasse, Toulouse FR
Patent application number | Description | Published |
---|---|---|
20100240084 | USE OF THE PROTIEN MABA (FABG1) OF MYCOBACTERIUM TUBERCULOSIS FOR DESIGNING AND SCREENING ANTIBIOTICS - The protein MabA, also named protein FabG1, which is recombinant in a purified form, or the recombinant proteins derived from the protein MabA by mutation of at least one amino acid. The uses of proteins MabA, or recombinant proteins derived from protein MabA by mutation of at lease one amino acid, proteins and to the crystalloghraphis co-ordinates thereof, in terms of the implementation of methods for designing and screening ligands of these proteins, and advantageously, ligands inhibiting the enzymatic activity of these proteins. | 09-23-2010 |